8-K Announcements
6Material company update
Apr 28, 2026·SEC
Material company update
Apr 24, 2026·SEC
Material company update
Mar 30, 2026·SEC
Universal Health Services, Inc.(UHS)Earnings, Financials & Key Ratios
UHS•NYSE
6.1× P/E·Price updated Jun 19, 2026
AboutUniversal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2022, it owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.Show more
- Revenue$17.36B+9.7%
- EBITDA$2.61B+15.3%
- Net Income$1.49B+30.4%
- EPS (Diluted)23.10+37.3%
- Gross Margin90.45%+0.5%
- EBITDA Margin15.05%+5.1%
- Operating Margin11.48%+8.1%
- Net Margin8.57%+18.8%
- ROE21.01%+19.3%
UHS Key Insights
Universal Health Services, Inc. (UHS) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High quality earnings: Operating CF exceeds net income
- ✓Good 3Y average ROE of 16.8%
- ✓Share count reduced 5.1% through buybacks
- ✓Trading at only 1.2x book value
- ✓Efficient asset utilization: 1.1x turnover
✗Weaknesses
- ✗Weak momentum: RS Rating 14 (bottom 14%)
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when UHS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
UHS Price & Volume
Universal Health Services, Inc. (UHS) stock price & volume — 10-year historical chart
Loading chart...
UHS Growth Metrics
Universal Health Services, Inc. (UHS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years6.74%
5 Years8.48%
3 Years9.03%
TTM10.42%
Profit CAGR
10 Years8.14%
5 Years9.54%
3 Years30.13%
TTM27.06%
EPS CAGR
10 Years13.07%
5 Years16.02%
3 Years36.21%
TTM33.73%
Return on Capital
10 Years12.76%
5 Years12.21%
3 Years13.28%
Last Year15.97%
UHS Recent Earnings
Universal Health Services, Inc. (UHS) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
Apr 27, 2026Metric
Actual
Est
EPS
$5.62+6.2%
$5.29
Rev
$4.5B+2.5%
$4.4B
Q1 2026
Feb 25, 2026Metric
Actual
Est
EPS
$5.88-0.7%
$5.92
Rev
$4.5B-0.4%
$4.5B
Q4 2025
Oct 27, 2025Metric
Actual
Est
EPS
$5.69+22.1%
$4.66
Rev
$4.5B-0.2%
$4.5B
Q3 2025
Jul 28, 2025Metric
Actual
Est
EPS
$5.35+8.7%
$4.92
Rev
$4.3B+1.1%
$4.2B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 27, 2026 | $5.62vs $5.29+6.2% | $4.5Bvs $4.4B+2.5% |
| Q1 2026 | Feb 25, 2026 | $5.88vs $5.92-0.7% | $4.5Bvs $4.5B-0.4% |
| Q4 2025 | Oct 27, 2025 | $5.69vs $4.66+22.1% | $4.5Bvs $4.5B-0.2% |
| Q3 2025 | Jul 28, 2025 | $5.35vs $4.92+8.7% | $4.3Bvs $4.2B+1.1% |
Based on last 12 quarters of dataView full earnings history →
UHS Peer Comparison
Universal Health Services, Inc. (UHS) competitors in Hospitals and inpatient facilities — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HCA | 83.88B | 375.17 | 13.22 | 7.08% | 8.97% | |||
 THC | 15.12B | 172.57 | 11.14 | 3.12% | 7.94% | 19.56% | 1.47 | |
 CYH | 425.61M | 3.02 | 0.80 | -1.18% | -0.41% | |||
 ENSG | 8.98B | 153.65 | 26.31 | 18.72% | 6.89% | 16.61% | 1.86 | |
 ACHC | 2.29B | 24.87 | -2.05 | 5.04% | -32.84% | -40.92% | 1.24 | |
 SEM | 2.05B | 16.54 | 14.02 | 5.12% | 2.42% | 6.57% | 1.82 | |
 SGRY | 1.9B | 14.55 | -23.85 | 6.24% | -2.28% | -2.15% | 1.14 | |
 USPH | 964.39M | 63.32 | 44.59 | 16.33% | 1.52% | 1.36% | 0.55 |
Compare UHS vs Peers
Universal Health Services, Inc. (UHS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
UHS Income Statement
Universal Health Services, Inc. (UHS) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 10.41B | 10.77B | 11.38B | 11.56B | 12.64B | 13.4B | 14.28B | 15.83B | 17.36B | 17.76B |
Revenue Growth % | 6.59% | 3.48% | 5.63% | 1.59% | 9.37% | 5.99% | 6.59% | 10.82% | 9.71% | 10.42% |
Cost of Goods Sold | 1.11B | 1.17B | 1.25B | 1.29B | 1.43B | 1.47B | 1.53B | 1.59B | 1.66B | 1.26B |
COGS % of Revenue | 10.62% | 10.85% | 11% | 11.14% | 11.29% | 11% | 10.73% | 10.03% | 9.55% | - |
Gross Profit | 9.3B▲ 0% | 9.6B▲ 3.2% | 10.13B▲ 5.4% | 10.27B▲ 1.4% | 11.21B▲ 9.2% | 11.93B▲ 6.3% | 12.75B▲ 6.9% | 14.24B▲ 11.7% | 15.71B▲ 10.3% | 12.01B▲ 0% |
Gross Margin % | 89.38% | 89.15% | 89% | 88.86% | 88.71% | 89% | 89.27% | 89.97% | 90.45% | 67.62% |
Gross Profit Growth % | 6.52% | 3.21% | 5.45% | 1.42% | 9.19% | 6.33% | 6.91% | 11.69% | 10.29% | - |
Operating Expenses | 8.02B | 8.43B | 8.91B | 8.91B | 9.85B | 10.92B | 11.57B | 12.56B | 13.71B | 10.47B |
OpEx % of Revenue | 77.09% | 78.24% | 78.32% | 77.1% | 77.93% | 81.51% | 81.04% | 79.34% | 78.96% | - |
Selling, General & Admin | 5.08B | 5.36B | 5.7B | 5.73B | 6.28B | 6.89B | 7.25B | 7.67B | 8.23B | 6.24B |
SG&A % of Revenue | 48.84% | 49.76% | 50.07% | 49.56% | 49.7% | 51.45% | 50.75% | 48.43% | 47.41% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | 2.94B | 3.07B | 3.21B | 3.18B | 3.57B | 4.03B | 4.33B | 4.89B | 5.48B | 3M |
Operating Income | 1.28B▲ 0% | 1.18B▼ 8.2% | 1.22B▲ 3.5% | 1.36B▲ 11.7% | 1.36B▲ 0.3% | 1B▼ 26.4% | 1.18B▲ 17.1% | 1.68B▲ 43.1% | 1.99B▲ 18.6% | 2.04B▲ 0% |
Operating Margin % | 12.3% | 10.91% | 10.69% | 11.75% | 10.78% | 7.49% | 8.23% | 10.63% | 11.48% | 11.5% |
Operating Income Growth % | -0.1% | -8.2% | 3.46% | 11.72% | 0.35% | -26.38% | 17.12% | 43.09% | 18.56% | - |
EBITDA | 1.73B | 1.63B | 1.71B | 1.87B | 1.9B | 1.59B | 1.74B | 2.27B | 2.61B | 2.67B |
EBITDA Margin % | 16.6% | 15.12% | 15% | 16.17% | 15% | 11.83% | 12.21% | 14.32% | 15.05% | 15.02% |
EBITDA Growth % | 1.76% | -5.77% | 4.79% | 9.53% | 1.47% | -16.39% | 9.97% | 30.01% | 15.27% | 14.01% |
D&A (Non-Cash Add-back) | 447.76M | 453.05M | 490.39M | 510.49M | 533.21M | 581.86M | 568.04M | 584.83M | 618.74M | 625.82M |
EBIT | 1.27B | 1.18B | 1.23B | 1.36B | 1.38B | 993.15M | 1.15B | 1.68B | 2.12B | 1.66B |
Net Interest Income | -142.77M | -154.96M | -162.73M | -106.28M | -83.67M | -126.89M | -206.67M | -186.11M | -156.07M | -114.76M |
Interest Income | 81K | 0 | 0 | 2.8M | 1.6M | 378K | 572K | 1.43M | 1.19M | 596K |
Interest Expense | 142.85M | 154.96M | 162.73M | 109.09M | 85.27M | 127.27M | 207.25M | 187.53M | 157.26M | 152.49M |
Other Income/Expense | -145.17M | -140.74M | -149.57M | -106.27M | -69.78M | -137.29M | -234.96M | -183.88M | -21.87M | -21.22M |
Pretax Income | 1.14B▲ 0% | 1.03B▼ 8.9% | 1.07B▲ 3.1% | 1.25B▲ 17.4% | 1.29B▲ 3.3% | 866.26M▼ 33.0% | 940.43M▲ 8.6% | 1.5B▲ 59.3% | 1.97B▲ 31.7% | 2.02B▲ 0% |
Pretax Margin % | 10.9% | 9.6% | 9.37% | 10.83% | 10.23% | 6.46% | 6.58% | 9.46% | 11.36% | 11.38% |
Income Tax | 363.7M | 236.64M | 238.79M | 299.29M | 305.68M | 209.28M | 221.12M | 334.83M | 460.96M | 472.6M |
Effective Tax Rate % | 32.04% | 22.87% | 22.39% | 23.9% | 23.64% | 24.16% | 23.51% | 22.35% | 23.37% | 23.39% |
Net Income | 752.3M▲ 0% | 779.71M▲ 3.6% | 814.85M▲ 4.5% | 943.95M▲ 15.8% | 991.59M▲ 5.0% | 675.61M▼ 31.9% | 717.79M▲ 6.2% | 1.14B▲ 59.1% | 1.49B▲ 30.4% | 1.52B▲ 0% |
Net Margin % | 7.23% | 7.24% | 7.16% | 8.17% | 7.84% | 5.04% | 5.03% | 7.22% | 8.57% | 8.56% |
Net Income Growth % | 7.1% | 3.64% | 4.51% | 15.84% | 5.05% | -31.87% | 6.24% | 59.11% | 30.36% | 27.06% |
Net Income (Continuing) | 771.31M | 797.88M | 827.54M | 952.79M | 987.63M | 656.98M | 719.31M | 1.16B | 1.51B | 1.54B |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 68.62M | 80.82M | 79.1M | 89.39M | 108.51M | 49.46M | 52.91M | 96.61M | 133.62M | 73.38M |
EPS (Diluted) | 7.81▲ 0% | 8.32▲ 6.5% | 9.13▲ 9.7% | 10.99▲ 20.4% | 11.82▲ 7.6% | 9.14▼ 22.7% | 10.23▲ 11.9% | 16.82▲ 64.4% | 23.10▲ 37.3% | -▲ 0% |
EPS Growth % | 9.38% | 6.53% | 9.74% | 20.37% | 7.55% | -22.67% | 11.93% | 64.42% | 37.34% | 33.73% |
EPS (Basic) | 7.86 | 8.36 | 9.16 | 11.06 | 11.99 | 9.23 | 10.35 | 17.16 | 23.42 | - |
Diluted Shares Outstanding | 96.33M | 93.75M | 89.04M | 85.59M | 83.69M | 73.83M | 70.13M | 67.9M | 64.46M | 0 |
Basic Shares Outstanding | 95.65M | 93.28M | 88.76M | 85.06M | 82.52M | 73.12M | 69.32M | 66.55M | 63.58M | 0 |
Dividend Payout Ratio | 5.08% | 4.79% | 6.5% | 1.84% | 6.65% | 8.65% | 7.73% | 4.67% | 3.44% | - |
UHS Balance Sheet
Universal Health Services, Inc. (UHS) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 1.8B | 1.94B | 1.92B | 3.28B | 2.26B | 2.54B | 2.81B | 2.82B | 3.41B | 3.5B |
Cash & Short-Term Investments | 74.42M | 105.22M | 61.27M | 1.22B | 115.3M | 102.82M | 119.44M | 125.98M | 137.8M | 119.03M |
Cash Only | 74.42M | 105.22M | 61.27M | 1.22B | 115.3M | 102.82M | 119.44M | 125.98M | 137.8M | 119.03M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 1.5B | 1.51B | 1.56B | 1.73B | 1.75B | 2.02B | 2.24B | 2.18B | 2.6B | 2.75B |
Days Sales Outstanding | 52.63 | 51.16 | 50.07 | 54.6 | 50.43 | 54.96 | 57.2 | 50.22 | 54.7 | 52.59 |
Inventory | 136.18M | 148.21M | 159.89M | 190.42M | 206.84M | 218.52M | 216.99M | 220.94M | 232.11M | 0 |
Days Inventory Outstanding | 44.98 | 46.29 | 46.64 | 53.96 | 52.9 | 54.1 | 51.67 | 50.79 | 51.07 | 49.51 |
Other Current Assets | 86.5M | 174.47M | 133.93M | 138.03M | 194.78M | 198.28M | 236.66M | 291.61M | 381.57M | 635.58M |
Total Non-Current Assets | 8.96B | 9.33B | 9.75B | 10.2B | 10.83B | 10.96B | 11.16B | 11.65B | 12.55B | 12.18B |
Property, Plant & Equipment | 4.57B | 4.85B | 5.34B | 5.71B | 6.24B | 6.37B | 6.56B | 6.99B | 7.38B | 13.99B |
Fixed Asset Turnover | 2.28x | 2.22x | 2.13x | 2.02x | 2.03x | 2.10x | 2.18x | 2.26x | 2.35x | 1.97x |
Goodwill | 3.83B | 3.84B | 3.87B | 3.88B | 3.96B | 3.91B | 3.93B | 3.93B | 3.99B | 3.98B |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 76.27M | 75.88M | 0 |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 318.73M | 346.23M | 680.47M |
Other Non-Current Assets | 563.83M | 629.83M | 523.15M | 579.97M | 579.9M | 605.89M | 579.73M | 216.19M | 254.5M | -5.85B |
Total Assets | 10.76B▲ 0% | 11.27B▲ 4.7% | 11.67B▲ 3.6% | 13.48B▲ 15.5% | 13.09B▼ 2.8% | 13.49B▲ 3.1% | 13.97B▲ 3.5% | 14.47B▲ 3.6% | 15.96B▲ 10.3% | 15.68B▲ 0% |
Asset Turnover | 0.97x | 0.96x | 0.98x | 0.86x | 0.97x | 0.99x | 1.02x | 1.09x | 1.09x | 1.15x |
Asset Growth % | 4.3% | 4.68% | 3.58% | 15.5% | -2.84% | 3.06% | 3.51% | 3.6% | 10.28% | 29.09% |
Total Current Liabilities | 1.85B | 1.45B | 1.56B | 2.48B | 1.98B | 1.91B | 2.01B | 2.21B | 3.24B | 3.24B |
Accounts Payable | 441.98M | 445.65M | 446.96M | 570.52M | 658.9M | 636.6M | 613.97M | 632M | 750.13M | 0 |
Days Payables Outstanding | 145.98 | 139.19 | 130.37 | 161.66 | 168.52 | 157.6 | 146.2 | 145.28 | 165.04 | 383.57 |
Short-Term Debt | 545.62M | 63.45M | 87.55M | 332M | 48.41M | 81.45M | 126.69M | 40.06M | 821.39M | 829.14M |
Deferred Revenue (Current) | 0 | 0 | 0 | 376.15M | 6K | 2.4M | 5.38M | 0 | 0 | 0 |
Other Current Liabilities | 343.22M | 472.53M | 524.63M | 410.17M | 466.35M | 470.86M | 549.47M | 622.63M | 984.56M | 2.41B |
Current Ratio | 0.97x | 1.34x | 1.23x | 1.32x | 1.14x | 1.33x | 1.40x | 1.27x | 1.05x | 1.08x |
Quick Ratio | 0.90x | 1.24x | 1.12x | 1.25x | 1.04x | 1.21x | 1.29x | 1.17x | 0.98x | 1.08x |
Cash Conversion Cycle | -48.38 | -41.74 | -33.66 | -53.11 | -65.19 | -48.54 | -37.33 | -44.27 | -59.27 | -281.48 |
Total Non-Current Liabilities | 3.86B | 4.35B | 4.52B | 4.59B | 4.91B | 5.61B | 5.75B | 5.5B | 5.31B | 4.91B |
Long-Term Debt | 3.49B | 3.94B | 3.9B | 3.52B | 4.14B | 4.73B | 4.79B | 4.46B | 4.26B | 4.3B |
Capital Lease Obligations | 0 | 0 | 270.08M | 278.3M | 304.62M | 395.52M | 382.56M | 376.24M | 426.1M | 1.12B |
Deferred Tax Liabilities | 54.96M | 49.66M | 25.07M | 5.58M | 0 | 0 | 0 | 0 | 435.14M | 438.38M |
Other Non-Current Liabilities | 306.3M | 361.81M | 329.93M | 458.55M | 464.76M | 487.67M | 584.01M | 655.81M | 187.11M | 606.06M |
Total Liabilities | 5.7B | 5.8B | 6.09B | 7.07B | 6.9B | 7.52B | 7.77B | 7.71B | 8.55B | 8.11B |
Total Debt | 4.04B | 4B | 4.31B | 4.19B | 4.56B | 5.27B | 5.37B | 4.96B | 5.51B | 5.13B |
Net Debt | 3.97B | 3.89B | 4.25B | 2.97B | 4.44B | 5.17B | 5.25B | 4.83B | 5.37B | 5.01B |
Debt / Equity | 0.80x | 0.73x | 0.77x | 0.65x | 0.74x | 0.88x | 0.87x | 0.73x | 0.74x | 0.67x |
Debt / EBITDA | 2.34x | 2.46x | 2.53x | 2.24x | 2.40x | 3.32x | 3.08x | 2.19x | 2.11x | 1.92x |
Net Debt / EBITDA | 2.29x | 2.39x | 2.49x | 1.59x | 2.34x | 3.26x | 3.01x | 2.13x | 2.06x | 1.88x |
Interest Coverage | 8.88x | 7.63x | 7.55x | 12.45x | 16.15x | 7.80x | 5.53x | 8.96x | 13.51x | 10.92x |
Total Equity | 5.06B▲ 0% | 5.47B▲ 8.1% | 5.58B▲ 2.1% | 6.41B▲ 14.7% | 6.2B▼ 3.3% | 5.97B▼ 3.7% | 6.2B▲ 3.9% | 6.76B▲ 9.0% | 7.41B▲ 9.6% | 7.6B▲ 0% |
Equity Growth % | 9.79% | 8.14% | 2.07% | 14.75% | -3.25% | -3.68% | 3.88% | 9.04% | 9.56% | 38.12% |
Book Value per Share | 52.51 | 58.35 | 62.70 | 74.85 | 74.06 | 80.86 | 88.44 | 99.61 | 114.94 | - |
Total Shareholders' Equity | 4.99B | 5.39B | 5.5B | 6.32B | 6.09B | 5.92B | 6.15B | 6.67B | 7.28B | 7.53B |
Common Stock | 942K | 914K | 867K | 851K | 771K | 710K | 672K | 650K | 611K | 7.46B |
Retained Earnings | 4.98B | 5.38B | 5.47B | 6.27B | 6.06B | 5.93B | 6.8B | 7.37B | 7.99B | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 7.18M | 4.24M | 31.89M | 48.12M | 30.29M | -9.67M | -650.6M | -706.5M | -717.57M | 0 |
Minority Interest | 68.62M | 80.82M | 79.1M | 89.39M | 108.51M | 49.46M | 52.91M | 96.61M | 133.62M | 73.38M |
UHS Cash Flow Statement
Universal Health Services, Inc. (UHS) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 1.18B | 1.34B | 1.44B | 2.36B | 883.7M | 996.02M | 1.27B | 2.07B | 1.86B | 1.91B |
Operating CF Margin % | 11.36% | 12.45% | 12.64% | 20.42% | 6.99% | 7.43% | 8.88% | 13.06% | 10.74% | - |
Operating CF Growth % | -8.22% | 13.39% | 7.28% | 64.08% | -62.56% | 12.71% | 27.29% | 63.05% | -9.81% | -6.03% |
Net Income | 771.31M | 797.88M | 827.54M | 952.79M | 987.63M | 656.98M | 717.49M | 1.16B | 1.51B | 1.52B |
Depreciation & Amortization | 447.88M | 453.08M | 490.39M | 510.49M | 533.21M | 581.86M | 568.04M | 584.83M | 618.74M | 625.82M |
Stock-Based Compensation | 56.74M | 66.58M | 69.43M | 65.84M | 73.69M | 85.38M | 87.72M | 99.35M | 95.69M | 72.48M |
Deferred Taxes | 0 | 49.52M | 90.09M | 3.32M | 26.05M | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | -79.19M | -76.15M | -97.78M | -109.76M | 0 | -83.85M | -124.34M | -198.95M | -85.32M | -314.13M |
Working Capital Changes | -14.16M | 49.98M | 58.79M | 940.81M | -736.89M | -244.35M | 17.07M | 418.76M | -275.89M | -2.1M |
Change in Receivables | -24.72M | -42.24M | -42.06M | -145.9M | -8.87M | -258.34M | -182.44M | 67.36M | -317.99M | -223.47M |
Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash from Investing | -624.4M | -813.4M | -688.41M | -802.56M | -914.47M | -647.3M | -763.27M | -911.11M | -1.07B | -996.9M |
Capital Expenditures | -609.43M | -811.67M | -663.52M | -734.21M | -855.66M | -734M | -743.05M | -943.81M | -1.02B | -1.01B |
CapEx % of Revenue | 5.85% | 7.53% | 5.83% | 6.35% | 6.77% | 5.48% | 5.2% | 5.96% | 5.85% | 5.7% |
Acquisitions | -15.08M | -15.23M | -14.58M | -54.78M | -105.31M | -20.31M | -3.73M | -18.72M | -31.94M | -26.24M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 108K | 13.5M | -10.31M | 8.07M | 46.51M | 12M | -16.51M | 51.42M | 28.69M | 44.17M |
Cash from Financing | -519.15M | -492.2M | -845.04M | -384.86M | -1.07B | -318.4M | -493.94M | -1.14B | -749.73M | -880.2M |
Debt Issued (Net) | -102.01M | -53.04M | -17.92M | -160.97M | 217.11M | 615.95M | 99.62M | -429.75M | 241.65M | 98.69M |
Equity Issued (Net) | -364.4M | -397.43M | -770.5M | -206.72M | -1.22B | -832.92M | -547.36M | -655.68M | -951.22M | -731.5M |
Dividends Paid | -38.21M | -37.34M | -53M | -17.34M | -65.9M | -58.45M | -55.48M | -53.35M | -51.27M | -50.71M |
Share Repurchases | -364.4M | -397.43M | -770.5M | -206.72M | -1.22B | -832.92M | -547.36M | -670.75M | -967.95M | -908.41M |
Other Financing | -14.54M | -4.4M | -3.61M | 172K | 715K | -42.99M | 9.28M | -6.09M | 11.11M | -196.69M |
Net Change in Cash | 40.68M▲ 0% | 32.39M▼ 20.4% | -94.02M▼ 390.3% | 1.17B▲ 1348.2% | -1.1B▼ 193.8% | 21.9M▲ 102.0% | 13.63M▼ 37.8% | 10.28M▼ 24.6% | 46.57M▲ 352.9% | -990K▲ 0% |
Free Cash Flow | 573.15M▲ 0% | 529.22M▼ 7.7% | 774.95M▲ 46.4% | 1.63B▲ 109.8% | 28.04M▼ 98.3% | 262.02M▲ 834.6% | 524.74M▲ 100.3% | 1.12B▲ 114.1% | 849.25M▼ 24.4% | 894.02M▲ 0% |
FCF Margin % | 5.51% | 4.91% | 6.81% | 14.07% | 0.22% | 1.96% | 3.67% | 7.1% | 4.89% | 5.03% |
FCF Growth % | 330.11% | -7.66% | 46.43% | 109.81% | -98.28% | 834.59% | 100.27% | 114.07% | -24.4% | -15.37% |
FCF per Share | 5.95 | 5.65 | 8.70 | 19.00 | 0.33 | 3.55 | 7.48 | 16.54 | 13.17 | - |
FCF Conversion (FCF/Net Income) | 1.57x | 1.72x | 1.77x | 2.50x | 0.89x | 1.47x | 1.77x | 1.81x | 1.25x | 0.59x |
Interest Paid | 135.53M | 150.29M | 157.41M | 112.6M | 75.61M | 120.14M | 200.45M | 168.27M | 0 | 75.33M |
Taxes Paid | 370.86M | 293.84M | 260.62M | 286.25M | 362.98M | 250.76M | 257.9M | 325.43M | 0 | 350.33M |
UHS Key Ratios
Universal Health Services, Inc. (UHS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 15.57% | 14.81% | 14.74% | 15.75% | 15.73% | 11.1% | 11.79% | 17.62% | 21.01% | 20.65% |
Return on Invested Capital (ROIC) | 10.83% | 9.59% | 9.5% | 10.61% | 10.21% | 6.91% | 7.81% | 10.95% | 12.27% | 12.33% |
Gross Margin | 89.38% | 89.15% | 89% | 88.86% | 88.71% | 89% | 89.27% | 89.97% | 90.45% | 67.62% |
Net Margin | 7.23% | 7.24% | 7.16% | 8.17% | 7.84% | 5.04% | 5.03% | 7.22% | 8.57% | 8.56% |
Debt / Equity | 0.80x | 0.73x | 0.77x | 0.65x | 0.74x | 0.88x | 0.87x | 0.73x | 0.74x | 0.67x |
Interest Coverage | 8.88x | 7.63x | 7.55x | 12.45x | 16.15x | 7.80x | 5.53x | 8.96x | 13.51x | 10.92x |
FCF Conversion | 1.57x | 1.72x | 1.77x | 2.50x | 0.89x | 1.47x | 1.77x | 1.81x | 1.25x | 0.59x |
Revenue Growth | 6.59% | 3.48% | 5.63% | 1.59% | 9.37% | 5.99% | 6.59% | 10.82% | 9.71% | 10.42% |
Related:UHS Dividend History·UHS Revenue History·UHS Price History·UHS P/E History·UHS Financial Ratios·UHS Institutional Holders
UHS SEC Filings & Documents
Universal Health Services, Inc. (UHS) SEC filings — annual & quarterly reports (10-K, 10-Q)
UHS Frequently Asked Questions
Universal Health Services, Inc. (UHS) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Universal Health Services, Inc. (UHS) reported $17.76B in revenue for fiscal year 2025. This represents a 1392% increase from $1.19B in 1996.
Universal Health Services, Inc. (UHS) grew revenue by 9.7% over the past year. This is steady growth.
Yes, Universal Health Services, Inc. (UHS) is profitable, generating $1.52B in net income for fiscal year 2025 (8.6% net margin).
Dividend & Returns
Yes, Universal Health Services, Inc. (UHS) pays a dividend with a yield of 0.56%. This makes it attractive for income-focused investors.
Universal Health Services, Inc. (UHS) has a return on equity (ROE) of 21.0%. This is excellent, indicating efficient use of shareholder capital.
Universal Health Services, Inc. (UHS) generated $894.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.